Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 2 (ZNF2) is a member of the zinc finger protein family, specifically the C2H2-type, and is presumed to function as a transcriptional regulator by binding DNA. Zinc finger proteins as a class are the largest family of transcription factors in the human genome, involved in diverse roles such as gene regulation, cell differentiation, apoptosis, and immune response. However, the exact biological and disease roles for ZNF2 specifically are not well characterized, and no direct therapeutic targeting, biomarker, or safety concern information is available. ZNF2 is encoded in humans by the ZNF2 gene. Like many zinc finger proteins, it likely modulates gene expression by binding to DNA through its zinc-coordinated finger domains. The broader zinc finger family is implicated in a number of diseases, especially cancers, but ZNF2 itself does not have well-documented disease links or drug interactions in published literature to date. No evidence was found that ZNF2 is currently recognized or targeted as a therapeutic protein or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 2 (ZNF2).